• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency.

作者信息

Valencic Erica, Grasso Antonio Giacomo, Conversano Ester, Lucafò Marianna, Piscianz Elisa, Gregori Massimo, Conti Francesca, Cancrini Caterina, Tommasini Alberto

机构信息

Department of Pediatrics, Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste, Italy.

Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

出版信息

J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2165-2167. doi: 10.1016/j.jaip.2018.02.029. Epub 2018 Mar 3.

DOI:10.1016/j.jaip.2018.02.029
PMID:29510232
Abstract
摘要

相似文献

1
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency.茶碱作为一名患有PIK3R1免疫缺陷的年轻女孩的精准治疗方法。
J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2165-2167. doi: 10.1016/j.jaip.2018.02.029. Epub 2018 Mar 3.
2
Theophylline for chronic obstructive pulmonary disease?....Time to move on.
Am J Respir Crit Care Med. 2010 Oct 1;182(7):868-9. doi: 10.1164/rccm.201008-1271ED.
3
Mixing the Old with the New: Drug Repurposing for Immune Deficiency in the Era of Precision Medicine and Pediatric Genomics.新旧结合：精准医学与儿科基因组学时代免疫缺陷病的药物再利用
J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2168-2169. doi: 10.1016/j.jaip.2018.04.002.
4
Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K.PIK3R1 杂合剪接突变导致人类免疫缺陷伴淋巴组织增生，原因是 PI3K 的显性激活。
J Exp Med. 2014 Dec 15;211(13):2537-47. doi: 10.1084/jem.20141759. Epub 2014 Dec 8.
5
Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in and .通过[具体基因1]和[具体基因2]中的免疫缺陷突变对PI3Kδ调节的构象破坏。
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1982-1987. doi: 10.1073/pnas.1617244114. Epub 2017 Feb 6.
6
Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two.PIK3R1 突变可导致 APDS2、SHORT 综合征或两者的组合。
Clin Immunol. 2017 Jun;179:77-80. doi: 10.1016/j.clim.2017.03.004. Epub 2017 Mar 14.
7
Precision medicine in the treatment of primary immunodeficiency diseases.原发性免疫缺陷病治疗中的精准医学
Curr Opin Allergy Clin Immunol. 2018 Apr;18(2):159-166. doi: 10.1097/ACI.0000000000000431.
8
[Theophylline and selective phosphodiesterase inhibitor in therapy of obstructive respiratory tract diseases].[茶碱与选择性磷酸二酯酶抑制剂在阻塞性呼吸道疾病治疗中的应用]
Pneumologie. 1997 Mar;51(3):303-16.
9
[Immediate results of treatment of psoriasis with phosphodiesterase inhibitors].[磷酸二酯酶抑制剂治疗银屑病的即时疗效]
Vestn Dermatol Venerol. 1979 May(5):21-5.
10
Phosphodiesterase type 4 inhibitors for asthma: a real breakthrough or just expensive theophylline?用于治疗哮喘的4型磷酸二酯酶抑制剂：是真正的突破还是只是昂贵的茶碱？
Ann Allergy Asthma Immunol. 2006 May;96(5):640-2. doi: 10.1016/S1081-1206(10)61060-5.

引用本文的文献

1
Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS).活化磷脂酰肌醇3-激酶δ综合征（APDS）患者的总生存期。
Orphanet J Rare Dis. 2025 May 3;20(1):212. doi: 10.1186/s13023-025-03734-z.
2
Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era.靶向治疗时代意大利活化磷脂酰肌醇3-激酶δ综合征队列报告。
J Clin Immunol. 2024 Dec 23;45(1):58. doi: 10.1007/s10875-024-01835-1.
3
Genetic Etiologies and Outcomes in Malignancy and Mortality in Activated Phosphoinositide 3-Kinase Delta Syndrome: A Systematic Review.
活化磷脂酰肌醇3-激酶δ综合征的遗传病因与恶性肿瘤及死亡率的结局：一项系统综述
Adv Ther. 2025 Feb;42(2):752-771. doi: 10.1007/s12325-024-03066-7. Epub 2024 Dec 5.
4
Activated phosphoinositde 3-kinase (PI3Kδ) syndrome: an Italian point of view on diagnosis and new advances in treatment.活化的磷酸肌醇 3-激酶（PI3Kδ）综合征：意大利在诊断和治疗新进展方面的观点。
Ital J Pediatr. 2024 May 20;50(1):103. doi: 10.1186/s13052-024-01662-5.
5
Druggable monogenic immune defects hidden in diverse medical specialties: Focus on overlap syndromes.隐藏于不同医学专科中的可药物治疗的单基因免疫缺陷：聚焦重叠综合征。
World J Clin Pediatr. 2022 Mar 9;11(2):136-150. doi: 10.5409/wjcp.v11.i2.136.
6
Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up.病例报告：4例活化PI3Kδ综合征患者中的EBV慢性感染与淋巴细胞增殖：准确特征描述、治疗及随访面临的挑战
Front Pediatr. 2021 Aug 27;9:703853. doi: 10.3389/fped.2021.703853. eCollection 2021.
7
Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient.病例报告：成人患者中霍奇金淋巴瘤与难治性系统性红斑狼疮揭示活化磷脂酰肌醇3-激酶δ综合征2型
Front Pediatr. 2021 Jul 8;9:702546. doi: 10.3389/fped.2021.702546. eCollection 2021.
8
Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies.原发性免疫缺陷诊断中的免疫与遗传学：处于变革之门的研究
Diagnostics (Basel). 2021 Mar 16;11(3):532. doi: 10.3390/diagnostics11030532.
9
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies.外显子组测序在常规诊断中的应用：对 254 例原发性免疫缺陷患者的通用检测。
Genome Med. 2019 Jun 17;11(1):38. doi: 10.1186/s13073-019-0649-3.
10
Off-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature.西罗莫司和依维莫司在儿科中心的超适应证使用：病例系列和文献复习。
Paediatr Drugs. 2019 Jun;21(3):185-193. doi: 10.1007/s40272-019-00337-7.